Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum NeutriSci International Inc V.NU.H

Alternate Symbol(s):  NRXCF

NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the production, and formulation of nutraceutical products within the business-to-business (B2B) industry. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans... see more

TSXV:NU.H - Post Discussion

NeutriSci International Inc > Glen has a long history
View:
Post by geodcan on Jul 22, 2021 2:25pm

Glen has a long history

of blowing off the book report.   Shareholders are getting pizzed off because we are not being put first.  A little something to clarify what is going on.  We have expectations from the danglers that have been put out there but our own due diligence comes with more questions than answers.

Somebody should be able to give us something on Japan sales from searching out storefronts or websites.  Who is producing the Tabletz?  Is it Tabletz or Neutrisci|?  Chryopharm or some white label outfit in Nevada?

This company seems to have been thrown a lifeline from their Neuenergy days which for all intents and purposes has ground to a halt for that product.  Took me totally by surprise when this Tabletz deal showed up and our association with Cryopharm, whatever it is and if there is something real there!  Cryopharm has a great looking line of products but I don't know if Neutrisci is getting any benefit from that angle or if we are just rubbing up on them from former associations.

It's time for Glen to do some straight shooting answers to shareholders because shareholders have to be put first in publicly traded companies.  Dates, delivery problems, manufacturing problems, supply problems, inspection problems, license problems, what is it? 

I consider this to be material information that should be disseminated to shareholders and done repectfully because without us, this is tanked.

Ed seems to have somebody stirred up enough at the home office to at least get a response that I have never been able to do after several tries even if they come off as a little schitzoid and unclear.

Not telling comes off the same as hiding the bad news.  It is time for some responsibility to show us that management is competent or step aside and let somebody else run with it.

Shareholders first!

glta and dyodd
Comment by Edcando on Jul 22, 2021 3:21pm
It's a bit of a catch 22. Not having what we consider to be the right amount /type of communication. Is a big point of contention. At the same time when they do release an update of things going on in principle we also become frustrated calling it vague fluff (if it's not vague and doesn't happen on time mentioned ) we are upset that there's a delay. I think that regardless of what ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities